A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors
Clinical trial NCT01139723 · COMPLETED
Trial details
- NCT number
- NCT01139723
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2014-08-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.